{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-022827","form_type":"8-K","ticker":"VERA","cik":"0001831828","company_name":"Vera Therapeutics, Inc.","filed_at":"2023-02-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.913285+00:00","generated_at":"2026-06-20T02:41:57.178699+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Vera Therapeutics announces $100M follow-on public offering of 14.3M shares at $7.00/share","bullets":["Underwriting agreement signed for 14,285,715 shares of Class A common stock at $7.00 per share.","Gross proceeds of approximately $100 million before underwriting discounts and offering expenses.","Closing expected February 6, 2023; underwriters have 30-day option for 2,142,857 additional shares.","Lead underwriters: J.P. Morgan, Cowen, and Evercore."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-022827","json":"https://secwatch.observer/filing/0001193125-23-022827.json","markdown":"https://secwatch.observer/filing/0001193125-23-022827.md","text":"https://secwatch.observer/filing/0001193125-23-022827.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831828/000119312523022827/0001193125-23-022827-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831828/000119312523022827/d456639d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T02:41:57.178699+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}